Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.

Van Houdt, M; Han, S N; Pauwels, S; Billen, J; Neven, P

Van Houdt, M; Han, S N; Pauwels, S; Billen, J; Neven, P.

Affiliation

Van Houdt M; Gynecology, University Hospitals of Leuven, Leuven. Electronic address: Maxime.vanhoudt@uzleuven.be.
Han SN; Gynecology, University Hospitals of Leuven, Leuven; Multidisciplinary Breast Center, University Hospitals of Leuven, Leuven.
Pauwels S; Department of Laboratory Medicine, University Hospitals of Leuven, Leuven.
Billen J; Department of Laboratory Medicine, University Hospitals of Leuven, Leuven.
Neven P; Gynecology, University Hospitals of Leuven, Leuven; Multidisciplinary Breast Center, University Hospitals of Leuven, Leuven.

Clin Breast Cancer ; 23(1): 84-90, 2023 01.

Article in En | MEDLINE | ID: mdl-36376236

Subject(s)

Breast Neoplasms; Adult; Female; Humans; Middle Aged; Aromatase Inhibitors/adverse effects; Chromatography, Liquid; Cross-Sectional Studies; Estradiol; Estrogens/therapeutic use; Estrone/therapeutic use; Gonadotropin-Releasing Hormone/therapeutic use; Retrospective Studies; Tamoxifen/therapeutic use; Tandem Mass Spectrometry

Key words

BMI; Estrogens; LHRH agonist; Ovarian function recovery

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google